Clinical characteristics of stage II and III CC patients (n = 284).

<p>Clinical characteristics of stage II and III CC patients (n = 284).</p

Box plots of the association between gene expression level for <i>ACSL1</i> and genotype for rs8086 SNP located on the 3’-UTR region.

<p>The box plots show how the <i>ACSL1</i> expression values are distributed for each genotype from the Additive, Dominant and Recessive model of inheritance for <i>ACSL1</i> rs8086 SNP in stage II and III CC patients. The p-values were calculated using the non-parametric Krustal-Wallis and Mann-Whitney tests, respectively. The line within the box indicate the median of level expression. The gene expression data were normalized using the geometric mean of the internal control genes <i>GAPDH</i> and <i>B2M</i>.</p

Kaplan-Meier curve of <i>ACSL1</i> SNP rs8086 and <i>SCD</i> SNP rs522951 on DFS for stage II and III CC patients in a recessive and dominant model of inheritance, respectively.

<p>P-value was calculated by Log-rank test.</p

Association between <i>ACSL1</i> and <i>SCD</i> gene expression level and the different genotypes from the diverse models of inheritance for <i>ACSL1</i> rs8086 and <i>SCD</i> rs522951 SNPs in stage II and III CC patients.

<p>Association between <i>ACSL1</i> and <i>SCD</i> gene expression level and the different genotypes from the diverse models of inheritance for <i>ACSL1</i> rs8086 and <i>SCD</i> rs522951 SNPs in stage II and III CC patients.</p